[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2018032555A1 - Method for preparing dihydroisoindole derivative and analogs thereof - Google Patents

Method for preparing dihydroisoindole derivative and analogs thereof Download PDF

Info

Publication number
WO2018032555A1
WO2018032555A1 PCT/CN2016/098431 CN2016098431W WO2018032555A1 WO 2018032555 A1 WO2018032555 A1 WO 2018032555A1 CN 2016098431 W CN2016098431 W CN 2016098431W WO 2018032555 A1 WO2018032555 A1 WO 2018032555A1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
formula
reaction
group
protecting group
Prior art date
Application number
PCT/CN2016/098431
Other languages
French (fr)
Chinese (zh)
Inventor
陈兴
王刚
罗建业
唐建
陈嘉昌
杨佑喆
Original Assignee
爱斯特(成都)生物制药股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 爱斯特(成都)生物制药股份有限公司 filed Critical 爱斯特(成都)生物制药股份有限公司
Publication of WO2018032555A1 publication Critical patent/WO2018032555A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Definitions

  • the invention belongs to the field of drug synthesis, and in particular relates to a preparation method of dihydroisoindole derivatives and analogs thereof.
  • Dihydroisoindole derivatives and their analogues are widely used in the fields of medicine, pesticides, etc., and can be used as key intermediates in many drugs.
  • a key part of a polycyclic compound which is highly effective in inhibiting hepatitis C virus disclosed in the patent CN102140100 is a dihydroisoindole derivative; a 1,3-dihydroisoindole derivative disclosed in CN101790518 is an HSP90 inhibitor.
  • CN00818254 discloses a pharmaceutically active dihydroisoindole derivative which is used as a TNFa and phosphodiesterase inhibitor and can For the treatment of TNFa and phosphodiesterase mediated diseases; the isoindole derivatives disclosed in US 4,400, 520 can be used for the treatment of rheumatoid arthritis, osteoarthritis, spondylolisthesis and post-operative, fracture, skeletal muscle pain and the like.
  • CN101790513 reports a process for preparing a derivative of isoindole-1,3-dione by reduction with a strong reducing agent to obtain a dihydroisoindole derivative, the specific route is as follows:
  • the isoindole-1,3-diketone derivative used in the method has no commercial product and needs to be synthesized in multiple steps and is expensive. Moreover, this method uses a highly hazardous reagent, borane, during the reduction process, and the yield of the final product is usually very low. For example, the yield of the 2,3-dihydro-5-hydroxy-1H-isoindole hydrochloride compound prepared by the method is only 20%, and the preparation of 5-bromo-2,3-dihydro-1H-isoindole is prepared. The rate is only 41.3%.
  • CN102140100 reports a method for derivatization and synthesis of other substituted dihydroisoindole derivatives in the case where the dihydroisoindole parent ring is completed, and the specific route is as follows:
  • the present invention provides a process for producing a dihydroisoindole derivative represented by the formula (I) and an analogue thereof, which comprises the steps of:
  • A represents O or NH
  • R 1 and R 2 are independently selected from C 1 -C 6 alkyl
  • a compound of the formula (I) is obtained by using a compound of the formula (IV) as a starting material.
  • the hydroxy protecting group is an etheric hydroxy protecting group or an ester hydroxy protecting group, preferably a methoxymethyl group.
  • amino protecting group is an alkyl-based amino protecting group, an amide-based amino protecting group or an imine-based amino protecting group, preferably a pivaloyl group.
  • the hydroxy protecting group is a methoxymethyl group.
  • the compound of formula (VII) of the present invention is reacted with chloromethyl methyl ether.
  • the amino protecting group is a pivaloyl group.
  • the compound of formula (VII) of the present invention is reacted with pivaloyl chloride.
  • R 1 is selected from a linear alkyl group of C 1 , C 2 or C 3 , and includes -CH 2 -, -CH 2 CH 2 - and -CH 2 CH 2 CH 2 -.
  • R 2 is selected from a methylene group.
  • the lithiation reagent is n-butyllithium, cyclohexyllithium, sec-butyllithium or tert-butyllithium; preferably n-butyllithium.
  • the formylating agent is N,N-dimethylformamide, ethyl formate or isopropyl formate.
  • the reaction temperature is -100 ° C to 50 ° C, preferably -80 ° C to 30 ° C, more preferably - 80 ° C to -30 ° C.
  • the reducing agent is sodium borohydride, potassium borohydride or lithium aluminum hydride.
  • the reaction temperature is -20 ° C to 30 ° C, preferably -10 ° C to 15 ° C.
  • step (4) comprises the following steps:
  • X represents Cl, Br, I, MsO or TsO;
  • Pga represents an amino protecting group
  • X represents Cl or Br
  • the halogenating reagent used is dichlorosulfoxide, sulfuryl chloride, phosphorus trichloride, phosphorus pentachloride, oxalyl chloride, phosphorus tribromide. Any one of phosphorus pentabromide.
  • the reaction temperature is from 0 ° C to 50 ° C, preferably from 20 ° C to 50 ° C.
  • the organic base is selected from any one or more of triethylamine, N-methylmorpholine, and diisopropylethylamine.
  • Pga is benzyl, 2-methylbenzyl, 3-methylbenzyl, 4-methylbenzyl, 2-methoxybenzyl, 3-methoxybenzyl or 4-methoxy Benzyl.
  • step (4) comprises the following steps:
  • X represents Cl, Br, I, MsO or TsO;
  • X represents Cl or Br
  • the halogenating reagent used is dichlorosulfoxide, sulfuryl chloride, phosphorus trichloride, phosphorus pentachloride, oxalyl chloride, phosphorus tribromide. Any one of phosphorus pentabromide.
  • the temperature of the reaction is from 0 ° C to 50 ° C, preferably from 15 ° C to 50 ° C.
  • PG is a pivaloyl group at this time.
  • the inorganic base is selected from the group consisting of sodium hydride, potassium hydride, potassium carbonate, cesium carbonate, and A Any one or more of sodium alkoxide, sodium ethoxide, sodium t-butoxide, and potassium t-butoxide.
  • the reaction temperature is -5 ° C to 100 ° C, preferably 0 ° C to 30 ° C.
  • the present invention also provides a preparation intermediate of the compound of the formula (I), that is, the compound of the formula V, the compound of the formula (VI), and more specifically, the intermediate structure of the preparation is the compound 5 in the specific embodiment. , 5a, 5b, 6, 6a, 6b.
  • the C 1 -C 6 alkyl group means an alkyl group of C 1 , C 2 , C 3 , C 4 , C 5 , C 6 , that is, a linear or branched alkyl group having 1 to 6 carbon atoms.
  • the reaction can be carried out in an alkaline environment, specifically in the presence of an organic base such as triethylamine, N-methylmorpholine and diisopropylethylamine.
  • the reaction can be carried out in an organic solvent, which may be a halogenated hydrocarbon solvent, an ether solvent, an ester solvent, and/or an aromatic hydrocarbon solvent, including dichloromethane, 1,2-dichloroethane, chloroform, Any one of tetrahydrofuran, methyl tert-butyl ether, acetic acid, ethyl ester, butyl acetate, toluene, and isopropyl acetate or a mixed solvent thereof.
  • the temperature of the reaction may range from -20 ° C to 80 ° C, with a preferred range of from -5 ° C to 50 ° C.
  • the reaction can be carried out in an organic solvent, and the organic solvent used may be an ether solvent including tetrahydrofuran, 2-methyltetrahydrofuran, diethyl ether, ethylene glycol dimethyl ether, methyl tert-butyl ether. One of them or a mixed solvent thereof.
  • the reaction temperature may range from -100 ° C to 50 ° C, preferably in the range of -80 ° C to 30 ° C, and further preferably -80 ° C to -30 ° C.
  • the reaction can be carried out in an organic solvent, and the organic solvent used may be water, an alcohol solvent and/or an ether solvent, including methanol, ethanol, propanol, butanol, isopropanol, tetrahydrofuran. Or one of 2-methyltetrahydrofuran and 1,4-dioxane or a mixed solvent thereof.
  • the reducing agent used may be sodium borohydride, potassium borohydride or lithium aluminum hydride.
  • the temperature of the reaction may range from -20 ° C to 30 ° C, with a preferred range of from -10 ° C to 30 ° C.
  • the compound of the formula (IVa) or the compound of the formula (IVb) may be dissolved in a solvent for reaction.
  • the solvent of the compound of the formula (IVa) or the solvent of the formula (IVb) may be used in dichloromethane, chloroform, 1,2-dichloroethane, toluene, xylene or chlorobenzene without directly reacting with a halogenated hydrocarbon solvent. Any one or a mixed solvent thereof.
  • PG pivaloyl
  • the temperature of the chlorination reaction ranges from 0 ° C to 50 ° C, and the preferred reaction range is from 20 ° C to 50 ° C.
  • the reaction may be carried out in an organic solvent, and the organic solvent used may be a halogenated hydrocarbon solvent, an ether solvent, an ester solvent, a nitrile solvent, and/or an aromatic hydrocarbon solvent, including One of tetrahydrofuran, 2-methyltetrahydrofuran, methyl tert-butyl ether, dichloromethane, chloroform, 1,2-dichloroethane, acetonitrile, toluene or a mixture thereof Soluble solvent.
  • the organic solvent used may be a halogenated hydrocarbon solvent, an ether solvent, an ester solvent, a nitrile solvent, and/or an aromatic hydrocarbon solvent, including One of tetrahydrofuran, 2-methyltetrahydrofuran, methyl tert-butyl ether, dichloromethane, chloroform, 1,2-dichloroethane, acetonitrile, toluene or a mixture thereof Soluble solvent.
  • the catalyst for the reaction is a palladium carbon catalyst having a palladium content of 3% to 10%, for example, Palladium hydroxide.
  • the solvent used for the reaction may be an alcohol solvent and/or an ether solvent, and one of methanol, ethanol, isopropanol, ethyl acetate, isopropyl acetate, butyl acetate or a mixed solvent thereof.
  • the hydrogen source used may be hydrogen, amine formate, hydrazine hydrate, cyclohexadiene or formic acid, preferably hydrogen.
  • the reaction can be carried out in an organic solvent, and the organic solvent used may be an ether solvent and/or an amide solvent, including N,N-dimethylformamide, tetrahydrofuran, 2-methyl One of tetrahydrofuran, ethylene glycol dimethyl ether, N-methylpyrrolidone or a mixed solvent thereof.
  • organic solvent used may be an ether solvent and/or an amide solvent, including N,N-dimethylformamide, tetrahydrofuran, 2-methyl One of tetrahydrofuran, ethylene glycol dimethyl ether, N-methylpyrrolidone or a mixed solvent thereof.
  • the deprotecting agent used when PG is a pivaloyl group, may be any one of concentrated hydrochloric acid, hydrobromic acid or trifluoroacetic acid.
  • the solvent used may be water, an alcohol solvent, a halogenated hydrocarbon solvent and/or an ether solvent, including methanol, ethanol, isopropanol, dichloromethane, 1,2-dichloroethane, 1,4-two. One of oxygen rings or a mixed solvent thereof.
  • the temperature for deprotection ranges from 0 °C to 130 °C, with a preferred range of from 40 °C to 100 °C.
  • test results show that the method of the present invention can produce dihydroisoindole derivatives and the like by a few simple reactions using inexpensive and readily available raw materials, and has high yield and purity.
  • the use of heavy metals is not involved, the problem of heavy metal residues existing in the preparation route is eliminated, and the safety of the final product as a medicine is improved.
  • EA Ethyl acetate MTBE Methyl tert-butyl ether MsO Mesylate TsO P-toluenesulfonate TLC TLC MS Mass spectrometry HPLC High performance liquid chromatography H-NMR Nuclear magnetic resonance spectrum DMF N,N-dimethylformamide THF Tetrahydrofuran MTBE Methyl tert-butyl ether DIPEA Diisopropylethylamine MOMCl Chloromethyl methyl ether EA Ethyl acetate
  • the liquid was separated, washed with water, washed with 1N HCl, washed with aqueous sodium hydrogencarbonate, and brine, and then evaporated, and then evaporated and evaporated to give the crude product, and the crude product was subjected to column to obtain 7 g of 5c product with a purity of 99% and a yield of 63%.
  • Conditional optimization is carried out using representative compounds as templates, and the optimum conditions are applicable to other substrates.
  • the method of the present invention uses a cheap and readily available raw material, and after several simple reactions, dihydroisoindole derivatives and the like can be obtained, and have high yield and purity.
  • the use of heavy metals is not involved, the problem of heavy metal residues existing in the preparation route is eliminated, and the safety of the final product as a medicine is improved.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A method for preparing a dihydroisoindole derivative and analogs thereof, comprising: using a compound of formula (VII) as a raw material, and protecting an amino group or a hydroxyl group to prepare a compound of formula (VI); using the compound of formula (VI) as a raw material to react with a lithiating agent, and then adding a formylating reagent for reaction to prepare a compound of formula (V); reducing a formyl group of the compound of formula (V) to a hydroxyl group with a reducing agent to prepare a compound of formula (IV); and preparing a compound of formula (I) by using the compound of formula (IV) as a raw material. The method uses readily available raw materials and fewer steps, has a relatively high yield and product purity, and improves the safety of products serving as drugs due to no use of heavy metals.

Description

二氢异吲哚衍生物及其类似物的制备方法Method for preparing dihydroisoindole derivatives and analogs thereof 技术领域Technical field
本发明属于药物合成领域,具体涉及二氢异吲哚衍生物及其类似物的制备方法。The invention belongs to the field of drug synthesis, and in particular relates to a preparation method of dihydroisoindole derivatives and analogs thereof.
背景技术Background technique
二氢异吲哚衍生物及其类似物广泛应用于医药、农药等领域,它可以作为许多药物的关键中间体。如专利CN102140100公开的一种高效抑制丙型肝炎病毒的多环化合物,其关键的一部分就是二氢异吲哚衍生物;CN101790518公开的1,3-二氢异吲哚衍生物,是HSP90抑制剂,并且可以用于制备治疗其中HSP90的抑制、调节或调控起作用的疾病的药物;CN00818254公开的具有药物活性的二氢异吲哚衍生物,是作为TNFa和磷酸二酯酶抑制剂,并可以用于治疗TNFa和磷酸二酯酶介导的疾病;US4400520公开的异吲哚衍生物,可以用于治疗风湿性关节炎、骨关节炎、椎关节强硬以及手术后、骨折、骨骼肌疼痛等。Dihydroisoindole derivatives and their analogues are widely used in the fields of medicine, pesticides, etc., and can be used as key intermediates in many drugs. A key part of a polycyclic compound which is highly effective in inhibiting hepatitis C virus disclosed in the patent CN102140100 is a dihydroisoindole derivative; a 1,3-dihydroisoindole derivative disclosed in CN101790518 is an HSP90 inhibitor. And can be used for the preparation of a medicament for treating a disease in which inhibition, modulation or regulation of HSP90 plays a role; CN00818254 discloses a pharmaceutically active dihydroisoindole derivative which is used as a TNFa and phosphodiesterase inhibitor and can For the treatment of TNFa and phosphodiesterase mediated diseases; the isoindole derivatives disclosed in US 4,400, 520 can be used for the treatment of rheumatoid arthritis, osteoarthritis, spondylolisthesis and post-operative, fracture, skeletal muscle pain and the like.
然而目前,文献和专利公开报道合成二氢异吲哚衍生物的方法较少,这些方法也难以适应于工业化大批量生产。例如:At present, however, the literature and patents disclose that there are few methods for synthesizing dihydroisoindole derivatives, and these methods are also difficult to adapt to industrial mass production. E.g:
CN101790513报道了将异吲哚-1,3-二酮的衍生物用强的还原剂还原制备得到二氢异吲哚衍生物的方法,具体路线如下:CN101790513 reports a process for preparing a derivative of isoindole-1,3-dione by reduction with a strong reducing agent to obtain a dihydroisoindole derivative, the specific route is as follows:
Figure PCTCN2016098431-appb-000001
Figure PCTCN2016098431-appb-000001
该方法中所用的异吲哚-1,3-二酮衍生物无商业化产品,需经多步合成,价格昂贵。并且,该方法在还原的过程中,使用高危险的试剂硼烷,且最终产物的收率通常很低。例如,该方法制备2,3-二氢-5-羟基-1H-异吲哚盐酸化合物的收率仅为20%,制备5-溴-2,3-二氢-1H-异吲哚的收率仅为41.3%。The isoindole-1,3-diketone derivative used in the method has no commercial product and needs to be synthesized in multiple steps and is expensive. Moreover, this method uses a highly hazardous reagent, borane, during the reduction process, and the yield of the final product is usually very low. For example, the yield of the 2,3-dihydro-5-hydroxy-1H-isoindole hydrochloride compound prepared by the method is only 20%, and the preparation of 5-bromo-2,3-dihydro-1H-isoindole is prepared. The rate is only 41.3%.
CN102140100报道了一种在二氢异吲哚母环构建完成的情况下进行衍生,合成其他取代的二氢异吲哚衍生物的方法,具体路线如下: CN102140100 reports a method for derivatization and synthesis of other substituted dihydroisoindole derivatives in the case where the dihydroisoindole parent ring is completed, and the specific route is as follows:
Figure PCTCN2016098431-appb-000002
Figure PCTCN2016098431-appb-000002
该方法的二氢异吲哚的母体合成未见有文献报道且市场上没有商业化产品供应,由该原料为起始物的合成路线,不适合商业化的生产应用。The parent synthesis of dihydroisoindole in this method has not been reported in the literature and there is no commercial product supply on the market. The synthetic route from the starting material is not suitable for commercial production applications.
Inorganica Chimica Acta,363(2010),3222-3228中报道了另一种常用方法,它是采用邻二卤苄和带氨基的化合物环合,脱N原子的保护基,得到二氢异吲哚的衍生物,具体路线如下:Another common method is reported in Inorganica Chimica Acta, 363 (2010), 3222-3228, which uses a sulfonate of an o-dibenzyl bromide and an amino group to deprotect the N atom to give a dihydroisoindole. Derivatives, the specific route is as follows:
Figure PCTCN2016098431-appb-000003
Figure PCTCN2016098431-appb-000003
该方法在最后一步脱保护基的时候,用到氢溴酸和苯酚,反应条件极为苛刻,其后处理的废物对环境影响极为不好,且该方法在苯环上有活泼取代基的时候,反应收率远达不到该文献的报道收率。When the method is deprotected in the last step, hydrobromic acid and phenol are used, the reaction conditions are extremely harsh, and the wastes treated thereafter have a very bad environmental impact, and when the method has active substituents on the benzene ring, The reaction yield is far below the reported yield of this document.
因此,目前亟需一种成本较低、适用于工业化大批量生产的二氢异吲哚衍生物及其类似物的制备方法。Therefore, there is a need for a process for the preparation of dihydroisoindole derivatives and analogs thereof which are relatively inexpensive and suitable for industrial mass production.
发明内容Summary of the invention
为解决上述问题,本发明提供了一种式(Ⅰ)所示的二氢异吲哚衍生物及其类似物的制备方法,它包括以下步骤:In order to solve the above problems, the present invention provides a process for producing a dihydroisoindole derivative represented by the formula (I) and an analogue thereof, which comprises the steps of:
Figure PCTCN2016098431-appb-000004
Figure PCTCN2016098431-appb-000004
其中,among them,
A表示O或NH;A represents O or NH;
当A表示O时,PG表示羟基保护基;当A表示NH时,PG表示氨基保护基; When A represents O, PG represents a hydroxy protecting group; when A represents NH, PG represents an amino protecting group;
R1和R2独立地选自C1~C6的烷基;R 1 and R 2 are independently selected from C 1 -C 6 alkyl;
(1)以式(Ⅶ)化合物为原料,将氨基或羟基保护,制备得到式(Ⅵ)化合物;(1) using a compound of the formula (VII) as a starting material, protecting an amino group or a hydroxyl group to prepare a compound of the formula (VI);
(2)以式(Ⅵ)化合物为原料与锂化试剂反应,再加入甲酰化试剂反应,制备得到式(Ⅴ)化合物;(2) reacting a compound of the formula (VI) with a lithiation reagent, and then adding a formylating reagent to prepare a compound of the formula (V);
(3)用还原剂将式(Ⅴ)化合物的甲酰基还原为羟基,制备得到式(Ⅳ)化合物;(3) reducing a formyl group of the compound of the formula (V) to a hydroxyl group with a reducing agent to prepare a compound of the formula (IV);
(4)以式(Ⅳ)化合物为原料制备得到式(Ⅰ)化合物。(4) A compound of the formula (I) is obtained by using a compound of the formula (IV) as a starting material.
进一步地,所述羟基保护基为醚类羟基保护基或酯类羟基保护基,优选为甲氧基甲基。Further, the hydroxy protecting group is an etheric hydroxy protecting group or an ester hydroxy protecting group, preferably a methoxymethyl group.
进一步地,所述氨基保护基为烷基类氨基保护基、酰胺类氨基保护基或亚胺类氨基保护基,优选为特戊酰基。Further, the amino protecting group is an alkyl-based amino protecting group, an amide-based amino protecting group or an imine-based amino protecting group, preferably a pivaloyl group.
进一步地,所述羟基保护基为甲氧基甲基。在一种具体的实施方式的步骤(1)中,本发明的式(Ⅶ)化合物与氯甲基甲醚反应。Further, the hydroxy protecting group is a methoxymethyl group. In step (1) of a specific embodiment, the compound of formula (VII) of the present invention is reacted with chloromethyl methyl ether.
进一步地,所述氨基保护基为特戊酰基。在一种具体的实施方式的步骤(1)中,本发明的式(Ⅶ)化合物与特戊酰氯反应。Further, the amino protecting group is a pivaloyl group. In step (1) of a specific embodiment, the compound of formula (VII) of the present invention is reacted with pivaloyl chloride.
进一步地,R1选自C1、C2或C3的直链烷基,包括-CH2-、-CH2CH2-和-CH2CH2CH2-。Further, R 1 is selected from a linear alkyl group of C 1 , C 2 or C 3 , and includes -CH 2 -, -CH 2 CH 2 - and -CH 2 CH 2 CH 2 -.
进一步地,R2选自亚甲基。Further, R 2 is selected from a methylene group.
进一步地,步骤(2)中,所述锂化试剂为正丁基锂、环己基锂、仲丁基锂或叔丁基锂;优选正丁基锂。Further, in the step (2), the lithiation reagent is n-butyllithium, cyclohexyllithium, sec-butyllithium or tert-butyllithium; preferably n-butyllithium.
进一步地,步骤(2)中,所述甲酰化试剂为N,N-二甲基甲酰胺、甲酸乙酯或甲酸异丙酯。Further, in the step (2), the formylating agent is N,N-dimethylformamide, ethyl formate or isopropyl formate.
进一步地,所述步骤(2)中的反应中,反应的温度为-100℃~50℃,优选-80℃~30℃,更优选-80℃~-30℃。Further, in the reaction in the step (2), the reaction temperature is -100 ° C to 50 ° C, preferably -80 ° C to 30 ° C, more preferably - 80 ° C to -30 ° C.
进一步地,步骤(3)中,所述还原剂为硼氢化钠、硼氢化钾、氢化铝锂。Further, in the step (3), the reducing agent is sodium borohydride, potassium borohydride or lithium aluminum hydride.
进一步地,所述步骤(3)的还原中,反应的温度为-20℃~30℃,优选-10℃~15℃。Further, in the reduction of the step (3), the reaction temperature is -20 ° C to 30 ° C, preferably -10 ° C to 15 ° C.
进一步地,当A表示O时,所述步骤(4)包括以下步骤:Further, when A represents O, the step (4) comprises the following steps:
Figure PCTCN2016098431-appb-000005
Figure PCTCN2016098431-appb-000005
其中,X表示Cl、Br、I、MsO或TsO;Wherein X represents Cl, Br, I, MsO or TsO;
Pga表示氨基保护基;Pga represents an amino protecting group;
(4a-1)以式(Ⅳa)化合物为原料,反应制备得到式(Ⅲa)化合物;(4a-1) using the compound of the formula (IVa) as a starting material, the reaction is prepared to obtain the compound of the formula (IIIa);
(4a-2)以式(Ⅲa)化合物为原料,在有机碱的存在下,与Pga-NH2反应制备得到式(Ⅱa)化合物;(4a-2) using the compound of the formula (IIIa) as a starting material, in the presence of an organic base, reacting with Pga-NH 2 to obtain a compound of the formula (IIa);
(4a-3)脱去氨基保护基,得到式(Ⅰ)化合物。(4a-3) Deprotection of the amino group provides the compound of formula (I).
进一步地,X表示Cl或Br,所述步骤(4a-1)的反应中,所用卤化试剂为二氯亚砜、磺酰氯、三氯化磷、五氯化磷、草酰氯、三溴化磷、五溴化磷中的任一种。Further, X represents Cl or Br, and in the reaction of the step (4a-1), the halogenating reagent used is dichlorosulfoxide, sulfuryl chloride, phosphorus trichloride, phosphorus pentachloride, oxalyl chloride, phosphorus tribromide. Any one of phosphorus pentabromide.
进一步地,所述步骤(4a-2)的反应中,反应的温度为0℃~50℃,优选20℃~50℃。Further, in the reaction of the step (4a-2), the reaction temperature is from 0 ° C to 50 ° C, preferably from 20 ° C to 50 ° C.
进一步地,步骤(4a-2)中,所述有机碱选自三乙胺、N-甲基吗啉、二异丙基乙基胺中的任一种或多种。Further, in the step (4a-2), the organic base is selected from any one or more of triethylamine, N-methylmorpholine, and diisopropylethylamine.
进一步地,Pga为苄基、2-甲基苄基、3-甲基苄基、4-甲基苄基、2-甲氧基苄基、3-甲氧基苄基或4-甲氧基苄基。Further, Pga is benzyl, 2-methylbenzyl, 3-methylbenzyl, 4-methylbenzyl, 2-methoxybenzyl, 3-methoxybenzyl or 4-methoxy Benzyl.
进一步地,当A表示NH时,所述步骤(4)包括以下步骤:Further, when A represents NH, the step (4) comprises the following steps:
Figure PCTCN2016098431-appb-000006
Figure PCTCN2016098431-appb-000006
其中,X表示Cl、Br、I、MsO或TsO;Wherein X represents Cl, Br, I, MsO or TsO;
(4b-1)以式(Ⅳb)化合物为原料,反应制备得到式(Ⅲb)化合物;(4b-1) using the compound of the formula (IVb) as a starting material, the reaction is prepared to obtain the compound of the formula (IIIb);
(4b-2)以式(Ⅲb)化合物为原料,在无机碱的存在下,分子内反应制备得到式(Ⅱa)化合物;(4b-2) using the compound of the formula (IIIb) as a starting material, in the presence of an inorganic base, in the intramolecular reaction to prepare a compound of the formula (IIa);
(4b-3)脱去氨基保护基,得到式(Ⅰ)化合物。(4b-3) Deprotection of the amino group provides the compound of formula (I).
进一步地,X表示Cl或Br,所述步骤(4b-1)的反应中,所用卤化试剂为二氯亚砜、磺酰氯、三氯化磷、五氯化磷、草酰氯、三溴化磷、五溴化磷中的任一种。Further, X represents Cl or Br, and in the reaction of the step (4b-1), the halogenating reagent used is dichlorosulfoxide, sulfuryl chloride, phosphorus trichloride, phosphorus pentachloride, oxalyl chloride, phosphorus tribromide. Any one of phosphorus pentabromide.
进一步地,所述步骤(4b-1)的反应中,反应的温度为0℃~50℃,优选15℃~50℃。在本发明一种具体的实施方式中,此时PG为特戊酰基。Further, in the reaction of the step (4b-1), the temperature of the reaction is from 0 ° C to 50 ° C, preferably from 15 ° C to 50 ° C. In a specific embodiment of the invention, PG is a pivaloyl group at this time.
进一步地,步骤(4b-2)中,所述无机碱选自氢化钠、氢化钾、碳酸钾、碳酸铯、甲 醇钠、乙醇钠、叔丁醇钠、叔丁醇钾中的任一种或多种。Further, in the step (4b-2), the inorganic base is selected from the group consisting of sodium hydride, potassium hydride, potassium carbonate, cesium carbonate, and A Any one or more of sodium alkoxide, sodium ethoxide, sodium t-butoxide, and potassium t-butoxide.
进一步地,所述步骤(4b-2)的反应中,反应的温度为-5℃~100℃,优选0℃~30℃。Further, in the reaction of the step (4b-2), the reaction temperature is -5 ° C to 100 ° C, preferably 0 ° C to 30 ° C.
本发明还提供了式(Ⅰ)所示化合物的制备中间体,即所述的式V化合物、式(VI)化合物,更为具体的,所述制备中间体结构为具体实施方式中的化合物5、5a、5b、6、6a、6b。The present invention also provides a preparation intermediate of the compound of the formula (I), that is, the compound of the formula V, the compound of the formula (VI), and more specifically, the intermediate structure of the preparation is the compound 5 in the specific embodiment. , 5a, 5b, 6, 6a, 6b.
所述C1~C6的烷基是指C1、C2、C3、C4、C5、C6的烷基,即具有1~6个碳原子的直链或支链的烷基,例如甲基、乙基、丙基、异丙基、丁基、异丁基、叔丁基、仲丁基、戊基、己基等等。The C 1 -C 6 alkyl group means an alkyl group of C 1 , C 2 , C 3 , C 4 , C 5 , C 6 , that is, a linear or branched alkyl group having 1 to 6 carbon atoms. For example, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, sec-butyl, pentyl, hexyl and the like.
对于前述步骤(1),该反应可以在碱性环境中进行,具体的可以是在有机碱存在的条件下,例如三乙胺、N-甲基吗啉和二异丙基乙基胺。该反应可以在有机溶剂中进行,有机溶剂可以为卤代烃类溶剂、醚类溶剂、酯类溶剂和/或芳香烃类溶剂,包括二氯甲烷、1,2-二氯乙烷、氯仿、四氢呋喃、甲基叔丁基醚、乙酸、乙酯、乙酸丁酯、甲苯、醋酸异丙酯中的任一种或其混合溶剂。反应的温度范围可以为-20℃-80℃,其优选的范围为-5℃-50℃。For the aforementioned step (1), the reaction can be carried out in an alkaline environment, specifically in the presence of an organic base such as triethylamine, N-methylmorpholine and diisopropylethylamine. The reaction can be carried out in an organic solvent, which may be a halogenated hydrocarbon solvent, an ether solvent, an ester solvent, and/or an aromatic hydrocarbon solvent, including dichloromethane, 1,2-dichloroethane, chloroform, Any one of tetrahydrofuran, methyl tert-butyl ether, acetic acid, ethyl ester, butyl acetate, toluene, and isopropyl acetate or a mixed solvent thereof. The temperature of the reaction may range from -20 ° C to 80 ° C, with a preferred range of from -5 ° C to 50 ° C.
对于前述步骤(2),该反应可以在有机溶剂中进行,所用的有机溶剂可以是醚类溶剂,包括四氢呋喃、2-甲基四氢呋喃、乙醚、乙二醇二甲醚、甲基叔丁基醚中的一种或其混合溶剂。反应的温度范围可以为-100℃-50℃,其优选的范围为-80℃-30℃,可进一步优选-80℃~-30℃。For the foregoing step (2), the reaction can be carried out in an organic solvent, and the organic solvent used may be an ether solvent including tetrahydrofuran, 2-methyltetrahydrofuran, diethyl ether, ethylene glycol dimethyl ether, methyl tert-butyl ether. One of them or a mixed solvent thereof. The reaction temperature may range from -100 ° C to 50 ° C, preferably in the range of -80 ° C to 30 ° C, and further preferably -80 ° C to -30 ° C.
对于前述步骤(3),该反应可以在有机溶剂中进行,所用的有机溶剂可以是水、醇类溶剂和/或醚类溶剂,包括甲醇、乙醇、丙醇、丁醇、异丙醇、四氢呋喃、2-甲基四氢呋喃、1,4-二氧六环中的一种或其混合溶剂。所用的还原试剂可以为硼氢化钠、硼氢化钾、或氢化铝锂。反应的温度范围可以为-20℃-30℃,其优选的范围为-10℃-30℃。For the foregoing step (3), the reaction can be carried out in an organic solvent, and the organic solvent used may be water, an alcohol solvent and/or an ether solvent, including methanol, ethanol, propanol, butanol, isopropanol, tetrahydrofuran. Or one of 2-methyltetrahydrofuran and 1,4-dioxane or a mixed solvent thereof. The reducing agent used may be sodium borohydride, potassium borohydride or lithium aluminum hydride. The temperature of the reaction may range from -20 ° C to 30 ° C, with a preferred range of from -10 ° C to 30 ° C.
对于前述步骤(4a-1)或(4b-1),作为本发明一种具体的实施方式,当X为氯时,式(Ⅳa)化合物或式(Ⅳb)化合物可以用溶剂溶解进行反应也可以不用溶剂直接和卤代烃类溶剂反应,所用溶解式(Ⅳa)化合物或式(Ⅳb)的溶剂可以为二氯甲烷、氯仿、1,2-二氯乙烷、甲苯、二甲苯、氯苯中的任一种或其混合溶剂。当PG为特戊酰基时,氯化反应的温度范围为0℃-50℃,其优选的反应范围为20℃-50℃。With respect to the aforementioned step (4a-1) or (4b-1), as a specific embodiment of the present invention, when X is chlorine, the compound of the formula (IVa) or the compound of the formula (IVb) may be dissolved in a solvent for reaction. The solvent of the compound of the formula (IVa) or the solvent of the formula (IVb) may be used in dichloromethane, chloroform, 1,2-dichloroethane, toluene, xylene or chlorobenzene without directly reacting with a halogenated hydrocarbon solvent. Any one or a mixed solvent thereof. When PG is pivaloyl, the temperature of the chlorination reaction ranges from 0 ° C to 50 ° C, and the preferred reaction range is from 20 ° C to 50 ° C.
对于前述步骤(4a-2),该反应可以在有机溶剂中进行,所用的有机溶剂可以为卤代烃类溶剂、醚类溶剂、酯类溶剂、腈类溶剂和/或芳香烃类溶剂,包括四氢呋喃、2-甲基四氢呋喃、甲基叔丁基醚、二氯甲烷、氯仿、1,2-二氯乙烷、乙腈、甲苯中的一种或其混 合溶剂。For the aforementioned step (4a-2), the reaction may be carried out in an organic solvent, and the organic solvent used may be a halogenated hydrocarbon solvent, an ether solvent, an ester solvent, a nitrile solvent, and/or an aromatic hydrocarbon solvent, including One of tetrahydrofuran, 2-methyltetrahydrofuran, methyl tert-butyl ether, dichloromethane, chloroform, 1,2-dichloroethane, acetonitrile, toluene or a mixture thereof Soluble solvent.
对于前述步骤(4a-3),作为本发明一种具体的实施方式,当Pga为苄基或取代苄基时,反应用的催化剂为可以3%-10%的钯含量的钯炭催化剂,例如氢氧化钯。反应所用的溶剂可以为醇类溶剂和/或醚类溶剂,包括甲醇、乙醇、异丙醇、乙酸乙酯、乙酸异丙酯、乙酸丁酯中的一种或其混合溶剂。所用的氢源可以为氢气、甲酸胺、水合肼、环己二烯或甲酸,优选的是氢气。For the foregoing step (4a-3), as a specific embodiment of the present invention, when Pga is a benzyl group or a substituted benzyl group, the catalyst for the reaction is a palladium carbon catalyst having a palladium content of 3% to 10%, for example, Palladium hydroxide. The solvent used for the reaction may be an alcohol solvent and/or an ether solvent, and one of methanol, ethanol, isopropanol, ethyl acetate, isopropyl acetate, butyl acetate or a mixed solvent thereof. The hydrogen source used may be hydrogen, amine formate, hydrazine hydrate, cyclohexadiene or formic acid, preferably hydrogen.
对于前述步骤(4b-2),该反应可以在有机溶剂中进行,所用的有机溶剂可以为醚类溶剂和/或酰胺类溶剂,包括N,N-二甲基甲酰胺、四氢呋喃、2-甲基四氢呋喃、乙二醇二甲醚,N-甲基吡咯烷酮中的一种或其混合溶剂。For the aforementioned step (4b-2), the reaction can be carried out in an organic solvent, and the organic solvent used may be an ether solvent and/or an amide solvent, including N,N-dimethylformamide, tetrahydrofuran, 2-methyl One of tetrahydrofuran, ethylene glycol dimethyl ether, N-methylpyrrolidone or a mixed solvent thereof.
对于前述步骤(4b-3),作为本发明一种具体的实施方式,当PG为特戊酰基时,所用的脱保护试剂可以为浓盐酸、氢溴酸或三氟乙酸中的任一种。所用的溶剂可以为水、醇类溶剂、卤代烃类溶剂和/或醚类溶剂,包括甲醇、乙醇、异丙醇、二氯甲烷、1,2-二氯乙烷、1,4-二氧六环中的一种或其混合溶剂。脱保护的温度范围为0℃-130℃,其优选的范围为40℃-100℃。With respect to the aforementioned step (4b-3), as a specific embodiment of the present invention, when PG is a pivaloyl group, the deprotecting agent used may be any one of concentrated hydrochloric acid, hydrobromic acid or trifluoroacetic acid. The solvent used may be water, an alcohol solvent, a halogenated hydrocarbon solvent and/or an ether solvent, including methanol, ethanol, isopropanol, dichloromethane, 1,2-dichloroethane, 1,4-two. One of oxygen rings or a mixed solvent thereof. The temperature for deprotection ranges from 0 °C to 130 °C, with a preferred range of from 40 °C to 100 °C.
试验结果显示,本发明方法使用便宜易得的原料,经过几步简单的反应,可制得二氢异吲哚衍生物及其类似物,并且具有较高的产率和纯度。同时,本发明的方法中,不涉及使用重金属,消除了制备路线中存在的重金属残留问题,提高了最终产品作为药物的安全性。The test results show that the method of the present invention can produce dihydroisoindole derivatives and the like by a few simple reactions using inexpensive and readily available raw materials, and has high yield and purity. At the same time, in the method of the invention, the use of heavy metals is not involved, the problem of heavy metal residues existing in the preparation route is eliminated, and the safety of the final product as a medicine is improved.
在本发明中,英文缩写对应的中文全称如下表所示:In the present invention, the full Chinese name corresponding to the English abbreviation is as follows:
EAEA 乙酸乙酯Ethyl acetate
MTBEMTBE 甲基叔丁基醚Methyl tert-butyl ether
MsOMsO 甲磺酸酯Mesylate
TsOTsO 对甲苯磺酸酯P-toluenesulfonate
TLCTLC 薄层色谱TLC
MSMS 质谱Mass spectrometry
HPLCHPLC 高效液相色谱High performance liquid chromatography
H-NMRH-NMR 核磁氢谱Nuclear magnetic resonance spectrum
DMFDMF N,N-二甲基甲酰胺N,N-dimethylformamide
THFTHF 四氢呋喃Tetrahydrofuran
MTBEMTBE 甲基叔丁基醚Methyl tert-butyl ether
DIPEADIPEA 二异丙基乙基胺Diisopropylethylamine
MOMClMOMCl 氯甲基甲基醚Chloromethyl methyl ether
EAEA 乙酸乙酯Ethyl acetate
DCMDCM 二氯甲烷Dichloromethane
DMSODMSO 二甲亚砜Dimethyl sulfoxide
CDCl3 CDCl 3 氘代氯仿Deuterated chloroform
显然,根据本发明的上述内容,按照本领域的普通技术知识和惯用手段,在不脱离本发明上述基本技术思想前提下,还可以做出其它多种形式的修改、替换或变更。It is apparent that various other modifications, substitutions and changes can be made in the form of the above-described embodiments of the present invention.
以下通过实施例形式的具体实施方式,对本发明的上述内容再作进一步的详细说明。但不应将此理解为本发明上述主题的范围仅限于以下的实例。凡基于本发明上述内容所实现的技术均属于本发明的范围。The above content of the present invention will be further described in detail below by way of specific embodiments in the form of embodiments. However, the scope of the above-mentioned subject matter of the present invention should not be construed as being limited to the following examples. Any technique implemented based on the above description of the present invention is within the scope of the present invention.
具体实施方式detailed description
下述实施例所用原料来自市售的商品,涉及的纯度均为HPLC纯度。The materials used in the following examples were from commercial products and the purity involved was HPLC purity.
实施例1 7,8-二氢-6H-[1,3]二氧[4,5-e]异吲哚盐酸盐(1)的合成Example 1 Synthesis of 7,8-dihydro-6H-[1,3]dioxo[4,5-e]isoindole hydrochloride (1)
Figure PCTCN2016098431-appb-000007
Figure PCTCN2016098431-appb-000007
往3000mL三口瓶中加入400g化合物7,400g三乙胺和2000g二氯甲烷,搅拌10min,冰水浴降温至0℃-5℃;开始缓慢滴加380g特戊酰氯,控制内部温度小于10℃,滴加完毕后,室温搅拌反应,TLC中控,反应2h,反应结束后,用1L 0.5N的稀盐酸调pH值至6-7,分液,有机相用水(1000mL)洗两次,150g元明粉干燥,抽滤,减压浓缩,石油醚打浆,抽滤,真空干燥得到576g化合物6,收率:92.6%,HPLC纯度:99.4%;质谱MS(M-H+):m/z 236.2,1H-NMR(400MHz,CDCl3):6.75(m,3H),5.94(s,2H),5.81(br1H),4.33(d,J=8.0Hz,2H),1.21(s,9H)。Add 400g of compound 7,400g of triethylamine and 2000g of dichloromethane to 3000mL three-necked flask, stir for 10min, cool down to 0 °C-5 °C in ice water bath; start slowly adding 380g of pivaloyl chloride slowly, control internal temperature less than 10 °C, drop After the addition is completed, the reaction is stirred at room temperature, controlled by TLC, and reacted for 2 h. After the reaction is completed, the pH is adjusted to 6-7 with 1 L of 0.5 N diluted hydrochloric acid, and the organic phase is washed twice with water (1000 mL), 150 g. powder sulfate, filtered, and concentrated under reduced pressure, slurried with petroleum ether, filtered off with suction, and dried in vacuo to give 576g of compound 6, yield: 92.6%, HPLC purity: 99.4%; mass spectrum MS (MH +): m / z 236.2,1H- NMR (400MHz, CDCl 3): 6.75 (m, 3H), 5.94 (s, 2H), 5.81 (br1H), 4.33 (d, J = 8.0Hz, 2H), 1.21 (s, 9H).
往10L三口瓶中加入530g化合物6和5.2L THF,氮气保护下搅拌至澄清,用液氮降温至-75℃,控制反应温度小于-70℃,滴加1.25L n-BuLi,滴加完毕后,反应0.5h,开始滴加250g DMF,控制反应温度不高于-70℃,滴加完毕后,-80℃--70℃反应0.5h,加水淬灭,用浓盐酸调pH值至2-3,1.0L MTBE萃取两次,减压回收溶剂,得到401g化合物5,收率:67.1%,纯度:99.9%;质谱MS(M-H+):m/z 264.2,1H-NMR(400MHz,CDCl3):10.33(s,1H),6.92(m,2H),6.12(s,2H),4.45(s,2H),1.13(s,9H)。Add 530 g of compound 6 and 5.2 L of THF to a 10 L three-necked flask, stir until clarified with nitrogen, cool to -75 ° C with liquid nitrogen, control the reaction temperature to less than -70 ° C, add 1.25 L of n-BuLi, and add dropwise , reaction 0.5h, start adding 250g DMF, control the reaction temperature is not higher than -70 ° C, after the completion of the addition, -80 ° C - 70 ° C reaction 0.5h, add water quenching, adjust the pH to 2 with concentrated hydrochloric acid 3, 1.0 L MTBE was extracted twice, and the solvent was recovered under reduced pressure to give 401 g of Compound 5, yield: 67.1%, purity: 99.9%; mass spectrum MS (MH + ): m/z 264.2, 1 H-NMR (400 MHz, CDCl 3 ): 10.33 (s, 1H), 6.92 (m, 2H), 6.12 (s, 2H), 4.45 (s, 2H), 1.13 (s, 9H).
往3L三口瓶中加入263g化合物5和2.6L甲醇,搅拌至澄清,冰水浴降温0℃-5℃, 控制温度小于10℃,分批加入30g硼氢化钠,加入完毕后,冰水浴下反应1小时,TLC中控,反应结束后,加入1000mL水,搅拌20min,用2L二氯甲烷萃取两次,合并有机相,减压浓缩得到240g化合物4,收率90.5%,纯度:99.7%;质谱MS(M-H+):m/z 264.1,1H-NMR(400MHz,CDCl3):6.79(d,J=8.0Hz,1H),6.72(d,J=8.0Hz,1H),6.47(br,1H),5.98(s,2H),4.74(d,J=4.0Hz,1H),4.43(d,J=4.0Hz,1H),3.13(t,J=4.0Hz,1H),1.16(s,9H)。Add 263g of compound 5 and 2.6L of methanol to the 3L three-necked flask, stir until clarified, cool the ice water bath to 0 °C-5 °C, control the temperature less than 10 °C, add 30g of sodium borohydride in batches, and add the reaction in ice water bath after adding After the reaction was completed, TLC was charged. After the reaction was completed, 1000 mL of water was added, stirred for 20 min, and extracted twice with 2 L of dichloromethane. The organic phase was combined and concentrated under reduced pressure to give 240 g of compound 4, yield: 90.5%, purity: 99.7%; (MH + ): m/z 264.1, 1 H-NMR (400MHz, CDCl 3 ): 6.79 (d, J = 8.0 Hz, 1H), 6.72 (d, J = 8.0 Hz, 1H), 6.47 (br, 1H) ), 5.98 (s, 2H), 4.74 (d, J = 4.0 Hz, 1H), 4.43 (d, J = 4.0 Hz, 1H), 3.13 (t, J = 4.0 Hz, 1H), 1.16 (s, 9H) ).
往3L三口瓶中加入2000mL二氯甲烷和205g化合物4,加热至内温25-30℃,化合物4的白色固体完全溶解,控制内温25-30℃滴加117g氯化亚砜,反应2h,TLC中控,原料消失后,降至室温,有类白色固体析出,抽滤,红外烘干,得到234g化合物3,收率:100%,纯度93.8%,质谱MS(M-H+):m/z 284.1,1H-NMR(400HMz,CDCl3):6.74-6.78(m,2H),6.01(s,3H),4.65(s,2H),4.43(d,2H),1.18(s,9H)。Add 2000 mL of dichloromethane and 205 g of Compound 4 to a 3 L three-necked flask, heat to an internal temperature of 25-30 ° C, completely dissolve the white solid of Compound 4, and control the internal temperature at 25-30 ° C to add 117 g of thionyl chloride, and react for 2 h. TLC control, after the disappearance of the raw materials, the temperature was lowered to room temperature, and an off-white solid precipitated, suction filtration and infrared drying to obtain 234 g of compound 3, yield: 100%, purity 93.8%, mass spectrum MS (MH + ): m/z 284.1,1H-NMR (400HMz, CDCl 3 ): 6.74-6.78 (m, 2H), 6.01 (s, 3H), 4.65 (s, 2H), 4.43 (d, 2H), 1.18 (s, 9H).
氮气保护下,往2000mL三口瓶中加入200g化合物3和1600mLDMF,搅拌至溶解,控制温度0-10℃分批加入84.7g氢化钠,反应1~1.5h,TLC中控,反应结束后,将反应液缓慢倒入盛有3000mL水的5000mL烧杯中,有白色固体产生,抽滤,洗涤,红外灯下烘干,得到177.5g化合物2类白色固体,收率92.6%,纯度81.3%;质谱MS(M-H+):m/z248.1,1H-NMR(400MHz,CDCl3):6.77(m,2H),5.99(s,2H),4.81-4.91(br,4H),1.34(s,9H)。Under nitrogen protection, add 200g of compound 3 and 1600mL of DMF to 2000mL three-necked bottle, stir until dissolved, control the temperature 0-10 °C, add 84.7g of sodium hydride in batches, react for 1~1.5h, control in TLC, after the reaction is finished, react The solution was slowly poured into a 5000 mL beaker containing 3000 mL of water, which was produced as a white solid, suction filtered, washed, and dried under an infrared lamp to obtain 177.5 g of compound 2 white solid, yield 92.6%, purity 81.3%; mass spectrometry MS ( MH + ): m/z 248.1, 1 H-NMR (400MHz, CDCl 3 ): 6.77 (m, 2H), 5.99 (s, 2H), 4.81-4.91 (br, 4H), 1.34 (s, 9H) .
往100mL三口瓶中加入6.37g粗品化合物2(90%含量),90mL的12N浓盐酸,加热至回流,TLC中控反应,10小时反应完全,降至室温,有灰白色固体产生,抽滤,得到类白色7,8-二氢-6H-[1,3]二氧[4,5-e]异吲哚盐酸盐1.63g,收率为34%,纯度:98.2%;质谱MS(M-H+):m/z 163.8,1H-NMR(400MHz,d6-DMSO):10.05(br,2H),6.94(d,J=8.0Hz,1H),6.87(d,J=8.0Hz,1H),6.08(s,2H),4.45(br,2H),4.40(br,2H)。Add 6.37g of crude compound 2 (90% content) to a 100mL three-necked flask, 90mL of 12N concentrated hydrochloric acid, heat to reflux, control reaction in TLC, complete reaction in 10 hours, drop to room temperature, produce off-white solid, suction filtration, get White-like 7,8-dihydro-6H-[1,3]dioxo[4,5-e]isoindole hydrochloride 1.63 g, yield 34%, purity: 98.2%; mass spectrum MS (MH + : m/z 163.8, 1 H-NMR (400 MHz, d6-DMSO): 10.05 (br, 2H), 6.94 (d, J = 8.0 Hz, 1H), 6.87 (d, J = 8.0 Hz, 1H), 6.08 (s, 2H), 4.45 (br, 2H), 4.40 (br, 2H).
实施例2 7,8-二氢-6H-[1,3]二氧[4,5-e]异吲哚盐酸盐(1)的合成Example 2 Synthesis of 7,8-dihydro-6H-[1,3]dioxo[4,5-e]isoindole hydrochloride (1)
Figure PCTCN2016098431-appb-000008
Figure PCTCN2016098431-appb-000008
往500mL三口瓶中加入25.0g化合物7a,100mL二氯甲烷,53.1g DIPEA。控制温度 10~20℃,滴加26.5g MOMCl,滴加完毕,保持15-25℃,反应16小时,TLC中控,反应完毕后加入200mL二氯甲烷,水洗,饱和食盐水洗,有机相减压浓缩,所得粗品过柱(石油醚:乙酸乙酯=10:1洗脱)得11.1g化合物6a,外观呈淡黄色油状物,收率86%;纯度:99%;质谱MS(M-H+):m/z 197.1,1H-NMR(400HMz,CDCl3):6.75-6.85(m,3H),5.93(s,2H),4.67(s,2H),4.48(s,2H),3.39(s,3H)。To a 500 mL three-necked flask was added 25.0 g of compound 7a, 100 mL of dichloromethane, and 53.1 g of DIPEA. Control the temperature 10 ~ 20 ° C, add 26.5g MOMCl, add dropwise, keep 15-25 ° C, reaction for 16 hours, TLC control, after the reaction is completed, add 200mL of dichloromethane, washed with water, washed with saturated brine, decompressed organic phase concentrated and the resulting crude product by column (petroleum ether: ethyl acetate = 10: 1 elution) to give 11.1g compound 6a, appearance of pale yellow oil, yield 86%; purity: 99%; mass MS (MH +): m / z 197.1,1H-NMR (400HMz , CDCl 3): 6.75-6.85 (m, 3H), 5.93 (s, 2H), 4.67 (s, 2H), 4.48 (s, 2H), 3.39 (s, 3H ).
往250mL三口瓶中加入8.0g化合物6a和80mL THF,氮气保护下搅拌至澄清,液氮降温至-78℃,控制温度小于-70℃滴加26.1mL n-BuLi,反应3-4h,滴加8.9g DMF,低温反应8-16小时,加氯化铵水溶液淬灭,回温至10-20℃。分液,水洗,1N的HCl洗,碳酸氢钠水溶液洗,饱和食盐水洗,浓缩有机相,得到粗品,将粗品进行过柱得到4.1g产品,收率45%,纯度99%;质谱MS(M-H+):m/z 225.1,1H-NMR(400MHz,CDCl3):10.33(s,1H),6.93-6.97(m,2H),6.11(s,2H),4.84(s,2H),4.71(s,2H),3.39(s,3H)。Add 8.0 g of compound 6a and 80 mL of THF to a 250 mL three-necked flask, stir until clarified under nitrogen atmosphere, cool the liquid nitrogen to -78 ° C, control the temperature to be less than -70 ° C, add 26.1 mL of n-BuLi, react 3-4 h, add dropwise 8.9 g DMF, low temperature reaction for 8-16 hours, quenched with aqueous ammonium chloride solution, and warmed to 10-20 °C. Separate, wash with water, wash with 1N HCl, wash with aqueous sodium hydrogencarbonate, and wash with brine, and then, then, then + ): m/z 225.1, 1 H-NMR (400MHz, CDCl 3 ): 10.33 (s, 1H), 6.93-6.97 (m, 2H), 6.11 (s, 2H), 4.84 (s, 2H), 4.71 (s, 2H), 3.39 (s, 3H).
往100mL三口瓶中加入4.5g化合物5a和36mL乙醇,搅拌10min,冰水浴降温至0-10℃,控制温度小于10℃,分批加入0.3g硼氢化钾,反应30min,TLC中控,原料反应完全,滴加3N的HCl调节pH=2左右,蒸除大部分乙醇,加入50mL水,EA萃取产品,有机相浓缩干得4.2g乳白色油状物,收率93%,纯度95%。Add 4.5g of compound 5a and 36mL of ethanol to 100mL three-necked flask, stir for 10min, cool to 0-10 °C in ice water bath, control temperature is less than 10 °C, add 0.3g potassium borohydride in batches, react for 30min, control in TLC, raw material reaction Completely, 3N HCl was added dropwise to adjust pH=2, most of the ethanol was distilled off, 50 mL of water was added, the product was extracted with EA, and the organic phase was concentrated to dryness to give 4.2 g of a white oil, yield 93%, purity 95%.
往100mL三口瓶中加入4.2g化合物4a和35mL二氯甲烷,搅拌10min,冰水浴降温至0-10℃,控制温度小于10℃,滴加14.3g三氯氧磷反应16h,TLC中控,反应完全后,旋干溶剂,粗品过柱纯化得2.6g化合物3a,收率63%,纯度99%;1H-NMR(400MHz,CDCl3):6.87(d,J=8.0Hz,1H),6.75(d,J=8.0Hz,1H),6.05(s,2H),4.76(s,2H),4.70(s,2H)。Add 4.2g of compound 4a and 35mL of dichloromethane to 100mL three-necked flask, stir for 10min, cool to 0-10 °C in ice water bath, control temperature is less than 10 °C, add 14.3g phosphorus oxychloride to react for 16h, control in TLC, reaction After completion, the solvent was evaporated to dryness, and the crude material was purified to give 2.6 g of Compound 3a, yield: 63%, purity 99%; 1 H-NMR (400 MHz, CDCl 3 ): 6.87 (d, J = 8.0 Hz, 1H), 6.75 (d, J = 8.0 Hz, 1H), 6.05 (s, 2H), 4.76 (s, 2H), 4.70 (s, 2H).
往30mL反应瓶中加入0.7g化合物3a和0.7g苄胺,1.2g DIPEA,14mL THF。升温60-70℃,反应16小时,TLC中控,反应结束后加入水,MTBE萃取产品。有机相蒸干,粗品过柱纯化得0.4g化合物2a;收率50%,纯度99%;质谱MS(M-H+):m/z 254.1,1H-NMR(400MHz,CDCl3):6.87(d,J=8.0Hz,1H),6.75(d,J=8.0Hz,1H),6.05(s,2H),4.76(s,2H),4.70(s,2H)。To a 30 mL reaction vial was added 0.7 g of compound 3a and 0.7 g of benzylamine, 1.2 g of DIPEA, 14 mL of THF. The temperature was raised at 60-70 ° C, the reaction was carried out for 16 hours, controlled by TLC, water was added after the reaction was completed, and the product was extracted by MTBE. The organic phase was evaporated to dryness, the crude product was purified by column to give Compound 2a 0.4g; yield 50%, purity 99%; Mass Spectrum MS (MH +): m / z 254.1, 1 H-NMR (400MHz, CDCl 3): 6.87 (d , J = 8.0 Hz, 1H), 6.75 (d, J = 8.0 Hz, 1H), 6.05 (s, 2H), 4.76 (s, 2H), 4.70 (s, 2H).
往30mL反应瓶中加入0.2g化合物2a和0.05g 10%钯碳,10mL乙醇和0.5mL 3N的HCl,N2置换3次,充氢至2-3kg压力,反应16-24小时,TLC中控,反应结束后垫硅藻土过滤,旋干,MTBE搅洗,得类白色固体7,8-二氢-6H-[1,3]二氧[4,5-e]异吲哚盐酸盐0.1g,收率60%,纯度99%,质谱MS(M-H+):m/z 168.3,1H-NMR(400MHz,d6-DMSO):10.05(br,2H),6.94(d,J=8.0Hz,1H),6.87(d,J=8.0Hz,1H),6.08(s,2H),4.45(br,2H),4.40(br,2H)。 Add 0.2g of compound 2a and 0.05g of 10% palladium carbon to 10mL reaction flask, 10mL of ethanol and 0.5mL of 3N HCl, replace N 2 with N 2 , charge hydrogen to 2-3kg pressure, react for 16-24 hours, control in TLC After the reaction, the mixture was filtered through celite, dried, and stirred with <RTI ID=0.0>>&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&& 0.1 g, yield 60%, purity 99%, mass spectrum MS (M-H+): m/z 168.3, 1 H-NMR (400 MHz, d 6 -DMSO): 10.05 (br, 2H), 6.94 (d, J = 8.0 Hz, 1H), 6.87 (d, J = 8.0 Hz, 1H), 6.08 (s, 2H), 4.45 (br, 2H), 4.40 (br, 2H).
实施例3 3,7,8,9-四氢-2H-[1,4]二氧[2,3-e]异吲哚盐酸盐(1b)的合成Example 3 Synthesis of 3,7,8,9-tetrahydro-2H-[1,4]dioxo[2,3-e]isoindole hydrochloride (1b)
Figure PCTCN2016098431-appb-000009
Figure PCTCN2016098431-appb-000009
往500mL三口瓶中加入42g化合物7b、400g N-甲基吗啉和250mL DCM,搅拌10min,冰水浴降温至10℃;开始缓慢滴加38g特戊酰氯,控制内部温度不高于20℃,滴加完毕后,室温搅拌反应,TLC中控,反应结束后,用100mL 0.5N的稀盐酸调pH值至6~7,分液,有机相用100mL水洗两次,15g元明粉干燥,抽滤,减压浓缩,石油醚打浆,抽滤,真空干燥得到55g化合物6b,纯度:99.1%,收率为86%。Add 42g of compound 7b, 400g of N-methylmorpholine and 250mL of DCM to a 500mL three-necked flask, stir for 10min, and cool to 10°C in an ice water bath; start slowly adding 38g of pivaloyl chloride slowly, and control the internal temperature to not exceed 20°C. After the addition is completed, the reaction is stirred at room temperature, controlled by TLC. After the reaction is finished, the pH is adjusted to 6-7 with 100 mL of 0.5 N diluted hydrochloric acid, and the organic phase is washed twice with 100 mL of water, and 15 g of the powder is dried and filtered. Concentrated under reduced pressure, petroleum ether was beaten, suction filtered, and dried under vacuum to give 55 g of compound 6b, purity: 99.1%, yield 86%.
往500mL三口瓶中加入50g化合物6b和300mL THF,氮气保护下搅拌至澄清,用液氮降温至-75℃,控制反应温度小于-70℃,滴加120mL环己基锂,滴加完毕后,反应0.5h,开始滴加30gDMF,控制反应温度不高于-70℃,滴加完毕后,-80℃--70℃反应2h,加水淬灭,用浓盐酸调pH值至2-3,150mL MTBE萃取两次,减压回收溶剂,得到38g化合物5b,纯度:97.6%,收率为68%。Add 50g of compound 6b and 300mL of THF to 500mL three-necked flask, stir to clarify under nitrogen atmosphere, cool to -75 °C with liquid nitrogen, control the reaction temperature to be less than -70 °C, add 120mL of cyclohexyllithium dropwise, after the addition is completed, the reaction 0.5h, start adding 30g DMF, control the reaction temperature is not higher than -70 ° C, after the completion of the addition, -80 ° C - 70 ° C reaction for 2h, add water to quench, adjust the pH to 2-3, 150mL MTBE with concentrated hydrochloric acid The mixture was extracted twice, and the solvent was evaporated under reduced pressure to give 38 g of Compound 5b, purity: 97.6%, yield 68%.
往500mL三口瓶中加入30g化合物5b和300mL甲醇,搅拌至澄清,冰水浴降温10℃,控制温度小于20℃,分批加入2.5g硼氢化钠,加入完毕后,冰水浴下反应1小时,TLC中控,反应结束后,加入100mL水,搅拌20min,用200mL DCM萃取两次,合并有机相,减压浓缩得到28g化合物4b,纯度:99.5%。收率为92%。Add 30g of compound 5b and 300mL of methanol to a 500mL three-necked flask, stir until clarified, cool the ice water bath to 10 ° C, control the temperature to less than 20 ° C, add 2.5g of sodium borohydride in batches, and then react in ice water bath for 1 hour, TLC In the middle of the reaction, after completion of the reaction, 100 mL of water was added, stirred for 20 min, extracted twice with 200 mL of DCM, and the organic phases were combined and concentrated under reduced pressure to give 28 g of compound 4b, purity: 99.5%. The yield was 92%.
往500mL三口瓶中加入250mL1,2-二氯乙烷和22g化合物4b,升温至50℃,,控制内温45~55℃滴加13g氯化亚砜,反应2h,TLC中控,原料消失后,降至室温,有类白色固体析出,抽滤,红外烘干,得到24g化合物3b,收率:100%,纯度95.8%,收率为99%。250 mL of 1,2-dichloroethane and 22 g of compound 4b were added to a 500 mL three-necked flask, and the temperature was raised to 50 ° C. The internal temperature was controlled at 45-55 ° C to add 13 g of thionyl chloride, and the reaction was carried out for 2 h. At room temperature, an off-white solid precipitated, suction filtration, and infrared drying to obtain 24 g of compound 3b, yield: 100%, purity 95.8%, yield 99%.
氮气保护下,往250mL三口瓶中加入20g化合物3b和150mLDMF,搅拌至溶解,控制温度0-10℃分批加入15g叔丁醇钾,反应1~1.5h,TLC中控,反应结束后,将反应液缓慢倒入盛有500mL水的2000mL烧杯中,有白色固体产生,抽滤,洗涤,红外灯下烘干,得到16g化合物2b类白色固体,纯度85.7%,收率为91%。。Under nitrogen protection, add 20g of compound 3b and 150mL of DMF to a 250mL three-necked flask, stir until dissolved, control the temperature 0-10 °C to add 15g of potassium t-butoxide in batches, react for 1 ~ 1.5h, control in TLC, after the reaction is over, The reaction solution was slowly poured into a 2000 mL beaker containing 500 mL of water, and a white solid was produced, suction filtered, washed, and dried under an infrared lamp to obtain 16 g of a compound 2b white solid having a purity of 85.7% and a yield of 91%. .
往250mL三口瓶中加入10g上步所得化合物2b、100mL乙醇和20%的浓盐酸50mL, 2g活性炭,加热至回流过夜,TLC中控反应完全,降至室温,抽滤,减压浓缩至干,加入20mL无水乙醇,冷冻结晶,抽滤,得到淡土黄色的固体,红外下烘干,得到3,7,8,9-四氢-2H-[1,4]二氧[2,3-e]异吲哚盐酸盐(1b)5.7g,HPLC纯度:99.1%,收率为70%;质谱MS(M-H+):m/z 177.9;1H-NMR(400MHz,d6-DMSO):10.1(br,2H),6.90(d,J=8.0Hz,1H),6.86(d,J=8.0Hz,1H),4.42(br,2H),4.36(br,2H),4.30(m,4H)。To a 250 mL three-necked flask, 10 g of the compound 2b obtained in the above step, 100 mL of ethanol, and 20 mL of concentrated hydrochloric acid 50 mL, 2 g of activated carbon were added, and the mixture was heated to reflux overnight, and the reaction was completely cooled to room temperature by TLC, suction filtered, and concentrated to dryness under reduced pressure. Add 20 mL of absolute ethanol, freeze crystallize, and suction filter to obtain a pale yellow solid. Dry it under infrared to obtain 3,7,8,9-tetrahydro-2H-[1,4]diox[2,3- e] isoindole hydrochloride (1b) 5.7 g, HPLC purity: 99.1%, yield 70%; mass spectrum MS (MH + ): m/z 177.9; 1 H-NMR (400 MHz, d 6 -DMSO) :10.1 (br, 2H), 6.90 (d, J = 8.0 Hz, 1H), 6.86 (d, J = 8.0 Hz, 1H), 4.42 (br, 2H), 4.36 (br, 2H), 4.30 (m, 4H).
实施例4 2,3,4,8,9,10-六氢-[1,4]二氧[2,3-e]异吲哚盐酸盐(1c)的合成Example 4 Synthesis of 2,3,4,8,9,10-hexahydro-[1,4]dioxo[2,3-e]isoindole hydrochloride (1c)
Figure PCTCN2016098431-appb-000010
Figure PCTCN2016098431-appb-000010
往500mL三口瓶中加入30.0g化合物7c,200mL二氯甲烷,60g DIPEA。控制温度低于20℃,滴加35g MOMCl,滴加完毕,保持15-25℃,反应16小时,TLC中控,反应完毕后加入100mL二氯甲烷,水洗,饱和食盐水洗,有机相减压浓缩,所得粗品过柱(石油醚:乙酸乙酯=10:1洗脱)得17g化合物6c,纯度:98%,收率46%。To a 500 mL three-necked flask was added 30.0 g of compound 7c, 200 mL of dichloromethane, 60 g of DIPEA. Control the temperature below 20 ° C, add 35g MOMCl, add dropwise, keep 15-25 ° C, reaction for 16 hours, TLC control, after the reaction is completed, add 100mL of dichloromethane, washed with water, saturated brine, organic phase concentrated under reduced pressure The obtained crude product was subjected to column ( petroleum ether: ethyl acetate = 10:1 elution) to give 17 g of compound 6c, purity: 98%, yield 46%.
往250mL三口瓶中加入10.0g化合物6c和100mL THF,氮气保护下搅拌至澄清,液氮降温至-78℃,控制温度小于-70℃滴加35mL n-BuLi,反应1h,滴加15mL甲酸乙酯,低温反应0.5小时,加氯化铵水溶液淬灭,回温至室温。分液,水洗,1N的HCl洗,碳酸氢钠水溶液洗,饱和食盐水洗,浓缩有机相,得到粗品,将粗品进行过柱得到7g 5c产品,纯度99%,收率63%。Add 10.0g of compound 6c and 100mL of THF to a 250mL three-necked flask, stir until clarified under nitrogen atmosphere, liquid nitrogen is cooled to -78 °C, control temperature is less than -70 °C, add 35mL of n-BuLi, react for 1h, add 15mL of formic acid The ester was reacted at low temperature for 0.5 hour, quenched with aqueous ammonium chloride solution, and warmed to room temperature. The liquid was separated, washed with water, washed with 1N HCl, washed with aqueous sodium hydrogencarbonate, and brine, and then evaporated, and then evaporated and evaporated to give the crude product, and the crude product was subjected to column to obtain 7 g of 5c product with a purity of 99% and a yield of 63%.
往100mL三口瓶中加入5g化合物5c和50mL甲醇,搅拌10min,冰水浴降温至0-10℃,控制温度小于20℃,分批加入2.5g氢化铝锂,反应30min,TLC中控,反应结束,滴加3NHCl调节pH=2左右,蒸除大部分甲醇,加入30mL水,EA萃取产品,有机相浓缩干得5g乳白色油状物,纯度98%,收率99%。Add 5g of compound 5c and 50mL of methanol to 100mL three-necked flask, stir for 10min, cool down to 0-10 °C in ice water bath, control temperature is less than 20 °C, add 2.5g lithium aluminum hydride in batches, react for 30min, control in TLC, the reaction is finished. 3N HCl was added dropwise to adjust pH=2, most of the methanol was distilled off, 30 mL of water was added, and the product was extracted with EA. The organic phase was concentrated to give 5 g of milky white oil, purity 98%, yield 99%.
往100mL三口瓶中加入5g化合物4c和50mL二氯甲烷,搅拌10min,冰水浴降温至0-10℃,控制温度小于10℃,滴加20g三溴化磷,反应2h,TLC中控,反应完全后,反应液缓慢加入到100mL水中,再加入100mL二氯甲烷,分层,有机相用饱和碳酸氢钠溶液洗涤,饱和食盐水洗,得到4g 3c,纯度91%,收率83%。 Add 5g of compound 4c and 50mL of dichloromethane to 100mL three-necked flask, stir for 10min, cool to 0-10 °C in ice water bath, control temperature is less than 10 °C, add 20g of phosphorus tribromide, react for 2h, control in TLC, complete reaction After that, the reaction solution was slowly added to 100 mL of water, and then 100 mL of dichloromethane was added thereto, and the layers were separated. The organic phase was washed with saturated sodium hydrogen carbonate solution and washed with saturated brine to give 4 g of 3c, purity 91%, yield 83%.
往100mL三口瓶中加入8g化合物3c和4g二苯甲胺,2g DIPEA,50mLTHF,升温60-70℃,反应16小时,TLC中控,反应结束后加入水,MTBE萃取产品。有机相蒸干,粗品过柱纯化得,5g化合物2c;纯度99%,收率55%。To a 100 mL three-necked flask, 8 g of compound 3c and 4 g of benzhydrylamine, 2 g of DIPEA, 50 mL of THF were added, and the temperature was raised at 60-70 ° C for 16 hours. TLC was controlled. After the reaction was completed, water was added and MTBE was extracted. The organic phase was evaporated to dryness.
往100mL反应瓶中加入4.5g化合物2c和0.5g 5%钯碳,50mL甲醇,2mL的12N浓盐酸,N2置换3次,充氢至2-3kg压力,反应20-24小时,TLC中控,反应结束后垫硅藻土过滤,旋干,MTBE搅洗,得类白色固体2,3,4,8,9,10-六氢-[1,4]二氧[2,3-e]异吲哚盐酸盐(1c)2g,纯度99%,收率56%,质谱MS(M-H+):m/z 191.9,1H-NMR(400MHz,d6-DMSO):10.10(br,2H),6.95(d,J=8.0Hz,1H),6.91(d,J=8.0Hz,1H),4.40(m,4H),4.20(t,J=6Hz,2H),4.15(t,J=6Hz,2H),2.20(m,2H)。Add 4.5g of compound 2c and 0.5g of 5% palladium carbon, 50mL of methanol, 2mL of 12N concentrated hydrochloric acid, N 2 for 3 times, charge hydrogen to 2-3kg pressure, react for 20-24 hours, and control in TLC. After the reaction is completed, the diatomaceous earth is filtered, spin-dried, and stirred with MTBE to obtain a white solid 2,3,4,8,9,10-hexahydro-[1,4]dioxy[2,3-e] Isoindole hydrochloride (1c) 2g, purity 99%, yield 56%, mass spectrum MS (M-H+): m/z 191.9, 1 H-NMR (400 MHz, d 6 -DMSO): 10.10 (br, 2H), 6.95 (d, J = 8.0 Hz, 1H), 6.91 (d, J = 8.0 Hz, 1H), 4.40 (m, 4H), 4.20 (t, J = 6 Hz, 2H), 4.15 (t, J =6 Hz, 2H), 2.20 (m, 2H).
实施5本发明工艺参数的筛选试验Performing 5 screening tests of process parameters of the present invention
1.关键步骤条件优化1. Key step condition optimization
以代表性化合物为模板进行条件优化,最佳的条件可适用于其他底物。Conditional optimization is carried out using representative compounds as templates, and the optimum conditions are applicable to other substrates.
1.1制备化合物5的条件优化1.1 Condition optimization for the preparation of compound 5
往100mL三口瓶中加入5.3g化合物6和52mL THF,氮气保护下搅拌至澄清,用液氮降温至一定温度,滴加1.25当量的锂化试剂,滴加完毕后,反应0.5h,开始滴加3当量的甲酰化试剂,控制反应0.5h,加水淬灭,用浓盐酸调pH值至2-3,100mL MTBE萃取两次,减压回收溶剂,得到化合物5,数据如下表1所示:Add 5.3 g of compound 6 and 52 mL of THF to a 100 mL three-necked flask, stir until clarified under nitrogen atmosphere, and cool to a certain temperature with liquid nitrogen, and add 1.25 equivalents of lithiation reagent. After the addition is completed, the reaction is started for 0.5 h. 3 equivalents of formylating reagent, control reaction for 0.5 h, quench with water, adjust the pH to 2-3 with concentrated hydrochloric acid, extract twice with 100 mL of MTBE, and recover the solvent under reduced pressure to obtain compound 5, the data is as shown in Table 1 below:
表1Table 1
Figure PCTCN2016098431-appb-000011
Figure PCTCN2016098431-appb-000011
1.2制备化合物4的条件优化 1.2 Optimization of conditions for the preparation of compound 4
往300L三口瓶中加入26.3g化合物5和260mL甲醇,搅拌至澄清,控制一定的温度,分批加入1.5当量的还原剂,加入完毕后,保温反应1小时,TLC中控,反应结束后,加入100mL水,搅拌20min,用200mL二氯甲烷萃取两次,合并有机相,减压浓缩得到化合物4,数据如下表2所示:Add 26.3g of compound 5 and 260mL of methanol to a 300L three-necked flask, stir until clarified, control a certain temperature, add 1.5 equivalents of reducing agent in batches, and after the addition, keep the reaction for 1 hour, control in TLC, after the reaction is over, add 100 mL of water, stirred for 20 min, extracted twice with 200 mL of dichloromethane, combined organics and concentrated under reduced pressure to give compound 4, as shown in Table 2 below:
表2Table 2
编号Numbering 反应温度(℃)Reaction temperature (°C) 还原剂reducing agent 收率Yield HPLC纯度(%)HPLC purity (%)
11 -10-10 硼氢化钠Sodium borohydride 90%90% 98%98%
22 -10-10 硼氢化钾Potassium borohydride 90%90% 98%98%
33 -10-10 氢化铝锂Lithium aluminum hydride 85%85% 98%98%
44 -20-20 硼氢化钠Sodium borohydride 88%88% 98%98%
55 2020 硼氢化钠Sodium borohydride 86%86% 98%98%
1.3制备化合物3的条件优化1.3 Optimization of conditions for the preparation of compound 3
往300mL三口瓶中加入200mL二氯甲烷和20.5g化合物4,搅拌溶解,控制在一定温度内滴加1.2当量卤化试剂,反应2h,TLC中控,原料消失后,降至室温,有类白色固体析出,抽滤,红外烘干,得到3,数据见下表3所示:Add 200mL of dichloromethane and 20.5g of compound 4 to a 300mL three-necked flask, stir and dissolve, control to add 1.2 equivalents of halogenating reagent in a certain temperature, react for 2h, control in TLC, disappear after the raw materials disappear, and have a white solid. Precipitation, suction filtration, infrared drying, get 3, the data is shown in Table 3 below:
表3table 3
Figure PCTCN2016098431-appb-000012
Figure PCTCN2016098431-appb-000012
1.4制备化合物2的条件优化1.4 Optimization of conditions for the preparation of compound 2
氮气保护下,往200mL三口瓶中加入20g化合物3和160mLDMF,搅拌至溶解,控 制一定温度分批加入2.5当量的碱,反应1~1.5h,TLC中控,反应结束后,将反应液缓慢倒入盛有300mL水的500mL烧杯中,有白色固体产生,抽滤,洗涤,红外灯下烘干,得化合物2类白色固体,数据见下表4所示:Under nitrogen protection, add 20g of compound 3 and 160mL of DMF to a 200mL three-necked bottle, stir until dissolved, control Add 2.5 equivalents of base in batches at a certain temperature, react for 1 to 1.5 hours, and control in TLC. After the reaction is finished, slowly pour the reaction solution into a 500 mL beaker containing 300 mL of water, which is produced as a white solid, suction filtered, and washed. Drying under infrared light gave compound 2 white solids. The data is shown in Table 4 below:
表4Table 4
编号Numbering Alkali 温度(℃)Temperature (°C) 收率(%)Yield (%) HPLC纯度(%)HPLC purity (%)
11 氢化钠Sodium hydride 55 8181 9797
22 氢化钾Potassium hydride 55 7878 9898
33 碳酸铯Barium carbonate 55 5656 9898
44 甲醇钠Sodium methoxide 55 23twenty three 8080
55 乙醇钠Sodium ethoxide 55 3434 8585
66 叔丁醇钠Sodium tert-butoxide 55 6060 8989
77 叔丁醇钾Potassium tert-butoxide 55 6767 9292
88 氢化钠Sodium hydride 3030 7575 9797
99 氢化钠Sodium hydride -5-5 3333 9898
综上所述,本发明方法使用便宜易得的原料,经过几步简单的反应,可制得二氢异吲哚衍生物及其类似物,并且具有较高的产率和纯度。同时,本发明的方法中,不涉及使用重金属,消除了制备路线中存在的重金属残留问题,提高了最终产品作为药物的安全性。 In summary, the method of the present invention uses a cheap and readily available raw material, and after several simple reactions, dihydroisoindole derivatives and the like can be obtained, and have high yield and purity. At the same time, in the method of the invention, the use of heavy metals is not involved, the problem of heavy metal residues existing in the preparation route is eliminated, and the safety of the final product as a medicine is improved.

Claims (10)

  1. 一种式(Ⅰ)化合物的制备方法,其特征在于:它包括以下步骤:A method for preparing a compound of formula (I), characterized in that it comprises the following steps:
    Figure PCTCN2016098431-appb-100001
    Figure PCTCN2016098431-appb-100001
    其中,among them,
    A表示O或NH;A represents O or NH;
    当A表示O时,PG表示羟基保护基;当A表示NH时,PG表示氨基保护基;When A represents O, PG represents a hydroxy protecting group; when A represents NH, PG represents an amino protecting group;
    R1和R2独立地选自C1~C6的烷基;R 1 and R 2 are independently selected from C 1 -C 6 alkyl;
    (1)以式(Ⅶ)化合物为原料,将氨基或羟基保护,制备得到式(Ⅵ)化合物;(1) using a compound of the formula (VII) as a starting material, protecting an amino group or a hydroxyl group to prepare a compound of the formula (VI);
    (2)以式(Ⅵ)化合物为原料与锂化试剂反应,再加入甲酰化试剂反应,制备得到式(Ⅴ)化合物;(2) reacting a compound of the formula (VI) with a lithiation reagent, and then adding a formylating reagent to prepare a compound of the formula (V);
    (3)用还原剂将式(Ⅴ)化合物的甲酰基还原为羟基,制备得到式(Ⅳ)化合物;(3) reducing a formyl group of the compound of the formula (V) to a hydroxyl group with a reducing agent to prepare a compound of the formula (IV);
    (4)以式(Ⅳ)化合物为原料制备得到式(Ⅰ)化合物;(4) preparing a compound of the formula (I) from a compound of the formula (IV);
    所述羟基保护基为醚类羟基保护基或酯类羟基保护基,优选为甲氧基甲基;The hydroxy protecting group is an ether hydroxy protecting group or an ester hydroxy protecting group, preferably a methoxymethyl group;
    所述氨基保护基为烷基类氨基保护基、酰胺类氨基保护基或亚胺类氨基保护基,优选为特戊酰基。The amino protecting group is an alkyl-based amino protecting group, an amide-based amino protecting group or an imine-based amino protecting group, preferably a pivaloyl group.
  2. 根据权利要求1所述的方法,其特征在于:R1选自C1、C2或C3的直链烷基。The method of claim 1 wherein R 1 is selected from a linear alkyl group of C 1 , C 2 or C 3 .
  3. 根据权利要求1或2所述的方法,其特征在于:R2选自亚甲基。The method according to claim 1 or 2, wherein R 2 is selected from the group consisting of methylene groups.
  4. 根据权利要求1-3任一项所述的方法,其特征在于:步骤(2)中,所述锂化试剂为正丁基锂、环己基锂、仲丁基锂或叔丁基锂;优选正丁基锂;The method according to any one of claims 1 to 3, wherein in the step (2), the lithiation reagent is n-butyllithium, cyclohexyllithium, sec-butyllithium or t-butyllithium; n-Butyllithium;
    所述甲酰化试剂为N,N-二甲基甲酰胺、甲酸乙酯或甲酸异丙酯;The formylating agent is N,N-dimethylformamide, ethyl formate or isopropyl formate;
    反应的温度为-100℃~50℃,优选-80℃~30℃,更优选-80℃~-30℃。The reaction temperature is -100 ° C to 50 ° C, preferably -80 ° C to 30 ° C, more preferably -80 ° C to -30 ° C.
  5. 根据权利要求1-4任一项所述的方法,其特征在于:步骤(3)中,所述还原剂为硼氢化钠、硼氢化钾或氢化铝锂;The method according to any one of claims 1 to 4, wherein in the step (3), the reducing agent is sodium borohydride, potassium borohydride or lithium aluminum hydride;
    反应的温度为-20℃~30℃,优选-10℃~15℃。 The reaction temperature is -20 ° C to 30 ° C, preferably -10 ° C to 15 ° C.
  6. 根据权利要求1-5任一项所述的方法,其特征在于:当A表示O时,所述步骤(4)包括以下步骤:The method according to any one of claims 1 to 5, wherein when A represents O, said step (4) comprises the steps of:
    Figure PCTCN2016098431-appb-100002
    Figure PCTCN2016098431-appb-100002
    其中,X表示Cl、Br、I、MsO或TsO;Wherein X represents Cl, Br, I, MsO or TsO;
    PGa表示氨基保护基;PGa represents an amino protecting group;
    (4a-1)以式(Ⅳa)化合物为原料,反应制备得到式(Ⅲa)化合物;(4a-1) using the compound of the formula (IVa) as a starting material, the reaction is prepared to obtain the compound of the formula (IIIa);
    (4a-2)以式(Ⅲa)化合物为原料,在有机碱的存在下,与Pga-NH2反应制备得到式(Ⅱa)化合物;(4a-2) using the compound of the formula (IIIa) as a starting material, in the presence of an organic base, reacting with Pga-NH 2 to obtain a compound of the formula (IIa);
    (4a-3)脱去氨基保护基,得到式(Ⅰ)化合物。(4a-3) Deprotection of the amino group provides the compound of formula (I).
  7. 根据权利要求6所述的方法,其特征在于:X表示Cl或Br,所述步骤(4a-1)的反应中,所用卤化试剂为二氯亚砜、磺酰氯、三氯化磷、五氯化磷、草酰氯、三溴化磷、五溴化磷中的任一种;The method according to claim 6, wherein X represents Cl or Br, and in the reaction of the step (4a-1), the halogenating reagent used is dichlorosulfoxide, sulfuryl chloride, phosphorus trichloride, pentachlorobenzene. Any of phosphorus, oxalyl chloride, phosphorus tribromide, and phosphorus pentabromide;
    所述步骤(4a-2)的反应中,反应的温度为0℃~50℃,优选20℃~50℃;所述有机碱选自三乙胺、N-甲基吗啉、二异丙基乙基胺中的任一种或多种;In the reaction of the step (4a-2), the reaction temperature is 0 ° C to 50 ° C, preferably 20 ° C to 50 ° C; the organic base is selected from the group consisting of triethylamine, N-methylmorpholine, diisopropyl Any one or more of ethylamine;
    Pga为苄基、2-甲基苄基、3-甲基苄基、4-甲基苄基、2-甲氧基苄基、3-甲氧基苄基或4-甲氧基苄基。Pga is benzyl, 2-methylbenzyl, 3-methylbenzyl, 4-methylbenzyl, 2-methoxybenzyl, 3-methoxybenzyl or 4-methoxybenzyl.
  8. 根据权利要求1-5任一项所述的方法,其特征在于:当A表示NH时,所述步骤(4)包括以下步骤:The method according to any one of claims 1 to 5, wherein when A represents NH, said step (4) comprises the steps of:
    Figure PCTCN2016098431-appb-100003
    Figure PCTCN2016098431-appb-100003
    其中,X表示Cl、Br、I、MsO或TsO; Wherein X represents Cl, Br, I, MsO or TsO;
    (4b-1)以式(Ⅳb)化合物为原料,反应制备得到式(Ⅲb)化合物;(4b-1) using the compound of the formula (IVb) as a starting material, the reaction is prepared to obtain the compound of the formula (IIIb);
    (4b-2)以式(Ⅲb)化合物为原料,在无机碱的存在下,分子内反应制备得到式(Ⅱa)化合物;(4b-2) using the compound of the formula (IIIb) as a starting material, in the presence of an inorganic base, in the intramolecular reaction to prepare a compound of the formula (IIa);
    (4b-3)脱去氨基保护基,得到式(Ⅰ)化合物。(4b-3) Deprotection of the amino group provides the compound of formula (I).
  9. 根据权利要求8所述的方法,其特征在于:X表示Cl或Br,所述步骤(4b-1)的反应中,所用卤化试剂为二氯亚砜、磺酰氯、三氯化磷、五氯化磷、草酰氯、三溴化磷、五溴化磷中的任一种;反应的温度为0℃~50℃,优选15℃~50℃;The method according to claim 8, wherein X represents Cl or Br, and in the reaction of the step (4b-1), the halogenating reagent used is thionyl chloride, sulfuryl chloride, phosphorus trichloride, pentachlorobenzene. Phosphorus, oxalyl chloride, phosphorus tribromide, phosphorus pentabromide; the reaction temperature is 0 ° C ~ 50 ° C, preferably 15 ° C ~ 50 ° C;
    步骤(4b-2)中,所述无机碱选自氢化钠、氢化钾、碳酸钾、碳酸铯、甲醇钠、乙醇钠、叔丁醇钠、叔丁醇钾中的任一种或多种;反应的温度为-5℃~100℃,优选0℃~30℃。In the step (4b-2), the inorganic base is selected from any one or more selected from the group consisting of sodium hydride, potassium hydride, potassium carbonate, cesium carbonate, sodium methoxide, sodium ethoxide, sodium t-butoxide, and potassium t-butoxide; The reaction temperature is -5 ° C to 100 ° C, preferably 0 ° C to 30 ° C.
  10. 式(Ⅰ)所示化合物的制备中间体:权利要求1~3中所述的式V化合物、式(VI)化合物。 Preparation of the compound of the formula (I): a compound of the formula V as defined in claims 1 to 3, a compound of the formula (VI).
PCT/CN2016/098431 2016-08-19 2016-09-08 Method for preparing dihydroisoindole derivative and analogs thereof WO2018032555A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201610696680.4 2016-08-19
CN201610696680.4A CN106366089B (en) 2016-08-19 2016-08-19 The preparation method of dihydroisoindole derivatives and the like

Publications (1)

Publication Number Publication Date
WO2018032555A1 true WO2018032555A1 (en) 2018-02-22

Family

ID=57878271

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2016/098431 WO2018032555A1 (en) 2016-08-19 2016-09-08 Method for preparing dihydroisoindole derivative and analogs thereof

Country Status (2)

Country Link
CN (1) CN106366089B (en)
WO (1) WO2018032555A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111233743A (en) * 2020-03-05 2020-06-05 温州大学新材料与产业技术研究院 2, 3-disubstituted indoline compound and preparation method and application thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112028816B (en) * 2020-09-11 2022-10-14 江阴迈康升华医药科技有限公司 Synthesis method of substituted isoindoline

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102140100A (en) * 2010-01-27 2011-08-03 爱博新药研发(上海)有限公司 Polycyclic compound for inhibiting hepatitis C virus efficiently, preparation method thereof and application thereof
WO2015070366A1 (en) * 2013-11-12 2015-05-21 Merck Sharp & Dohme Corp. Aryl linked imidazole and triazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug
US20160122318A1 (en) * 2014-11-05 2016-05-05 Vitae Pharmaceuticals, Inc. Isoindoline inhibitors of ror-gamma

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4400520A (en) * 1980-09-10 1983-08-23 Hisamitsu Pharmaceutical Co., Inc. Novel process for preparing isoindoline derivatives
DE102007041116A1 (en) * 2007-08-30 2009-03-05 Merck Patent Gmbh 1,3-dihydro-isoindole derivatives
CN105189508B (en) * 2013-03-19 2018-11-23 默沙东公司 Naphthenic base nitrile Pyrazolopyridine ketone as JANUS kinase inhibitor
CN105524045B (en) * 2014-10-22 2020-04-10 山东轩竹医药科技有限公司 Tetracyclic anaplastic lymphoma kinase inhibitors

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102140100A (en) * 2010-01-27 2011-08-03 爱博新药研发(上海)有限公司 Polycyclic compound for inhibiting hepatitis C virus efficiently, preparation method thereof and application thereof
WO2015070366A1 (en) * 2013-11-12 2015-05-21 Merck Sharp & Dohme Corp. Aryl linked imidazole and triazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug
US20160122318A1 (en) * 2014-11-05 2016-05-05 Vitae Pharmaceuticals, Inc. Isoindoline inhibitors of ror-gamma

Non-Patent Citations (15)

* Cited by examiner, † Cited by third party
Title
ALALLA, A. ET AL.: "Green Synthesis of Benzamides in Solvent and Activation-Free Conditions", SYNTHETIC COMMUNICATIONS, vol. 44, no. 16, 13 June 2014 (2014-06-13), pages 2364 - 2376, XP055469579, ISSN: 0039-7911 *
DATABASE REGISTRY 16 November 1984 (1984-11-16), retrieved from STN Database accession no. 6471-96-1 *
DATABASE REGISTRY 17 April 2016 (2016-04-17), retrieved from STN Database accession no. 1891165-68-6 *
DATABASE REGISTRY 22 April 2016 (2016-04-22), retrieved from STN Database accession no. 1895358-19-6 *
DATABASE REGISTRY 26 December 2008 (2008-12-26), retrieved from STN Database accession no. 1090472-69-7 *
DATABASE REGISTRY 3 August 2008 (2008-08-03), retrieved from STN Database accession no. 1038044-09-5 *
DATABASE REGISTRY 9 July 2015 (2015-07-09), retrieved from STN Database accession no. 1798127-53-3 *
DATABASE REGISTRY 9 July 2015 (2015-07-09), retrieved from STN Database accession no. 1798183-81-9 *
KING, F.J. ET AL.: "Stereoelectronic Suppression and a Remarkably Low Effective Concentration for a Cyclization to a Benzo-fused Five-membered Ring", J. CHEM. SOC., CHEM. COMMUN., 1 January 1988 (1988-01-01), pages 147 - 148, ISSN: 0022-4936 *
NICHOLS, E.D. ET AL.: "Steric Effects of Substituents on Phenethylamine Hallucinogene. 3,4-(Methylenedioxy) amphetamine Analogues Alkylated on the Dioxole Ring", JOURNAL OF MEDICINAL CHEMISTRY, vol. 22, no. 10, 31 December 1979 (1979-12-31), pages 1264 - 1267, XP002419340, ISSN: 0022-2623 *
SCHLOSSER, M. ET AL.: "The Organometallic Route to Benzylamine Type Monoamine Oxidase Inhibitors", TETRAHEDRON, vol. 54, no. 34, 31 December 1998 (1998-12-31), pages 10119 - 10124, XP004129988, ISSN: 0040-4020 *
SIMIG, G.: "ANew Route to Isoindole Intermediates", SYNLETT, 31 July 1990 (1990-07-31), pages 425 - 426, XP055469577, ISSN: 0936-5214 *
SIMIG, G.: "Synthesis of 1,2-Dihydroisoquinoline-3-carbaldehydes", J. CHEM. SOC. PERKIN TRANS., 31 December 1992 (1992-12-31), pages 1613 - 1616, ISSN: 0300-922X *
WU, PUHUA ET AL.: "Novel pyrrolobenzoxaboroles: Design, synthesis, and biological evaluation against Trypanosoma brucei", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 81, 29 April 2014 (2014-04-29), pages 59 - 75, XP028851816, ISSN: 0223-5234 *
ZENG, TIEQIANG ET AL.: "Separation, Recovery and Reuse of N-heterocyclic Carbene Catalysts in Transesterification Reactions", CHEM. COMMUN., 3 September 2009 (2009-09-03), pages 6249 - 6251, XP055469582, ISSN: 1359-7345 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111233743A (en) * 2020-03-05 2020-06-05 温州大学新材料与产业技术研究院 2, 3-disubstituted indoline compound and preparation method and application thereof
CN111233743B (en) * 2020-03-05 2024-01-23 温州大学新材料与产业技术研究院 2, 3-disubstituted indoline compound and preparation method and application thereof

Also Published As

Publication number Publication date
CN106366089B (en) 2019-06-11
CN106366089A (en) 2017-02-01

Similar Documents

Publication Publication Date Title
US8153648B2 (en) Solid and crystalline dutasteride and processes for preparation thereof
KR102266680B1 (en) Polymorphic Forms of Belinostet and Methods of Making It
WO2022214645A1 (en) Processes and intermediates for the preparation of relugolix
JP2003506425A (en) Method for producing nitroxyalkyl ester of naproxen
EP4015519A1 (en) Method of preparing asenapine
WO2018032555A1 (en) Method for preparing dihydroisoindole derivative and analogs thereof
US20040220278A1 (en) Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
EP2178864B1 (en) Process for the preparation of alfuzosin hydrochloride
US20110087042A1 (en) Crystalline oxybutynin and process for preparing the same
JPH09500632A (en) Process for producing substituted 4,6-diamino-5-cyanopyrimidines
US8093384B2 (en) Processes for the preparation of alfuzosin
US20240336603A1 (en) Process for the preparation of a cyp11a1 inhibitor and intermediates thereof
WO2018133533A1 (en) Montelukast sodium intermediate, preparation method and application thereof
WO2012056468A1 (en) A process for the preparation of bosentan
CN109988070B (en) Intermediate of trans-1-hydroxy-1- (trifluoromethyl) -3-aminocyclobutane hydrochloride, preparation method and application
JP2979358B2 (en) Phenothiazine derivatives
CN111793071B (en) Synthetic process of augustine
CN115785081A (en) Preparation method of raltitrexed
JPH0576473B2 (en)
WO2003064377A1 (en) 4,5-substituted-2-formylaminobenzamides and processes for their production and conversion
KR20040097930A (en) For the synthesis of n-methyl-n-phenylaminoacrolein
JPS58164573A (en) Manufacture of 1-(4-chlorobenzoyl)-5-methoxy- 2-methyl-3-indole acetoxyacetic acids
TW201215612A (en) Synthetic method of entecavir and intermediate compounds thereof
JPS6335634B2 (en)
KR20000033173A (en) Preparation method of phenyl propionic acid derivatives or their salts

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16913310

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16913310

Country of ref document: EP

Kind code of ref document: A1